Novartis Pharmaceuticals Corp. has settled the remainder of gender bias claims brought by women field representatives who claimed they were discriminated against in pay, promotion and in pregnancy policies. The company and lawyers for plaintiffs, led by David Sanford of Sanford, Wittels & Heisler, announced the company will pay upwards of $152.5 million to potentially thousands of female employees who are current or former sales representatives from 2002 to 2007. About $60 million of the settlement will cover back pay.
The agreement, which still must be approved by a federal judge in Manhattan, also calls for an additional $22.5 million to be paid for company programs to eliminate discrimination.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
